Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | BIRC3 loss accelerates leukemic progression in CLL

Miguel Quijada-Álamo, Universidad de Salamanca-CSIC, Hospital Universitario, Salamanca, Spain, talks about BIRC3 loss and the acceleration of leukemic progression in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.